Oxidative stress and pathological changes after coronary artery interventions

Rio P Juni1, Henricus J Duckers, Paul M Vanhoutte

  • 1Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, the Netherlands.

Insights

Reactive oxygen species (ROS) generated during coronary interventions contribute to cardiovascular disorders like restenosis and thrombosis. New stent technologies aim to mitigate this oxidative stress for improved procedural success.

Area of Science:

  • Cardiovascular Science
  • Oxidative Stress Research
  • Interventional Cardiology

Background:

  • Oxidative stress is a key factor in cardiovascular disease pathogenesis.
  • Coronary interventions increase reactive oxygen species (ROS), impairing vascular cell function and potentially causing restenosis, thrombosis, or endothelial dysfunction.
  • Understanding ROS generation post-intervention is crucial for improving procedural outcomes.

Purpose of the Study:

  • To review the molecular mechanisms of ROS generation following coronary interventions.
  • To discuss the pathological consequences of ROS, including restenosis, endothelial dysfunction, and stent thrombosis.
  • To explore therapeutic strategies targeting oxidative stress and nitric oxide bioavailability.

Main Methods:

  • Literature review of studies on oxidative stress in cardiovascular disorders.
  • Analysis of ROS generation pathways (e.g., NADPH oxidase, xanthine oxidase, mitochondria) after coronary interventions.
  • Examination of current and emerging stent technologies designed to combat oxidative stress.

Main Results:

  • Superoxide anions (O2(·-)) are identified as particularly harmful ROS, scavenging nitric oxide and promoting inflammation.
  • ROS contribute to endothelial dysfunction, smooth muscle cell proliferation, and adverse vascular remodeling.
  • Novel stent designs (biodegradable, NO-releasing, advanced drug-eluting) aim to reduce post-intervention oxidative stress.

Conclusions:

  • Targeting ROS generation and improving nitric oxide bioavailability are critical for enhancing the success of coronary interventions.
  • Further research into ROS-mediated pathways can lead to more effective preventative and therapeutic strategies.
  • Innovations in stent technology offer promising avenues for managing oxidative stress in the treated vasculature.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation